Pfizer and biontech receive first u.s. fda emergency use authorization of a covid-19 vaccine in children ages 5 through 11 years

New york and mainz, germany, october 29, 2021 — pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) has authorized for emergency use the pfizer-biontech covid-19 vaccine for children 5 through 11 years of age (also referred to as 5 to
BNTX Ratings Summary
BNTX Quant Ranking